Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 2:04 AM ET | Feedback | Site Changes | Help
The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.
View Ticker Page (DNA)
Results 31 - 40 of 269 : 12345Next »
Recs
dudleya (96.99) Submitted: 4/11/07 12:27 PM : Start Price: $82.24 DNA Score: 25.41
Best big biotech company
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
dplindeman (98.93) Submitted: 4/11/07 5:59 PM : Start Price: $82.60 DNA Score: 24.75
GENENTECH IS POSITIONED AS A MEDICAL RESEARCH LEADER. GOOD GROWTH AND EARNINGS ESPECIALLY WHEN COMPARED TO COMPETITORS. JUST NEED THE FEDS TO LET UP ON STEM CELL RESEARCH. JUST A MATTER OF TIME
ryanhodge (< 20) Submitted: 4/13/07 11:39 AM : Start Price: $81.15 DNA Score: 27.06
Company was a little lackluster recently but financials show its strong with good revenue growth and operating profit. Not to mention that if this company hits with a good cancer drug its trading price will look like Berkshire Hathaway.
r3n3gade6 (71.19) Submitted: 3/14/08 12:09 AM : Start Price: $80.05 DNA Score: 21.84
Strong financials with a strong product pipeline and strong indications for current product portfolio. Several products with reasonable expecations of patent and indication extensions.
slcarner (< 20) Submitted: 3/31/08 12:36 PM : Start Price: $81.19 DNA Score: 20.05
I work for Genentech, the pipeline is full of very promising drugs, some that will change the way medicine is practiced. Some of these are in phase 3 right now, and by 2009-2010 time frame you should see some great things from this company.
dustbusterz (< 20) Submitted: 9/06/07 12:33 PM : Start Price: $78.97 DNA Score: 31.48
Qtrly Revenue Growth (yoy): 36.60%Qtrly Earnings Growth (yoy): 40.70%Operating Cash Flow (ttm): 2.65BReturn on Assets (ttm): 18.41%Return on Equity (ttm): 27.33%with growing revenue. i think this one is set to take off.
KingPortu (52.60) Submitted: 10/11/07 12:13 PM : Start Price: $75.44 DNA Score: 40.17
Biotech has stunk for what seems like forever, but this company has revenue growth of nearly 40%! Solid balance sheet and a LOT of top line medications. Cancer is more and more prevalent by the day and 'old school' chemo treatments are becoming a thi...
JuMoOlAn (51.82) Submitted: 10/04/06 5:19 AM : Start Price: $83.86 DNA Score: 17.38
DNA looks cheap to growth rate
esxokm (98.48) Submitted: 9/19/06 8:29 AM : Start Price: $79.70 DNA Score: 21.89
I believe the baby-boomer-population-will-need-all-kinds-of-drugs-so-buy-biotech thesis; this is one that could be owned for the long-term.
spacebased (87.21) Submitted: 9/19/06 2:25 AM : Start Price: $79.70 DNA Score: 21.89
A great drug company that has it's ups and downs. If there were a cycle for this type of thing, then DNA is due. It's been down a long time.
Terms & Conditions
RSS Headlines
Fool UK